For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year-old Alyssa was in remission, and she continues to do well several months later.
I received the new gene-editing drug for sickle cell disease. It changed my life.
CNN - Health Archives – Page 72 of 100 – KION546
CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer - Computational and Structural Biotechnology Journal
Buildings November 2021 - Browse Articles
Spencer Waspi on LinkedIn: Russia/Ukraine Energy Implications
Recent advances in gene therapy: genetic bullets to the root of the problem
Alexa Miller on LinkedIn: I want to thank RiboClub for welcoming Revvity to their annual RNA…
Spencer Waspi on LinkedIn: It turns out it's a great week to say thank you to a number of people for…
How CRISPR Is Changing Cancer Research and Treatment - NCI
Nanomaterials May-2 2023 - Browse Articles
How CRISPR Is Changing Cancer Research and Treatment - NCI
HOPA Bulletin
Alexa Miller on LinkedIn: CRISPR-Cas9: From Bacterial Adaptive Immune Response To Editing and…